1. Cladribine tablets added to IFN-β in active relapsing MS: The ONWARD study. Issue 5 (September 2018) Authors: Montalban, Xavier; Leist, Thomas P.; Cohen, Bruce A.; Moses, Harold; Campbell, Jackie; Hicking, Christine; Dangond, Fernando; Comi, Giancarlo; Gallo, Paolo; Pozzilli, Carlo; Gasperini, Claudio; Morra, Vincenzo Brescia; Boyko, Alexey N; Amelina, Olga; Kotov, Sergey V; Novikova, Lilia; Patrusheva, ... Journal: Neurology Issue: Volume 5:Issue 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2020) Authors: Cree, Bruce A C; Cutter, Gary; Wolinsky, Jerry S; Freedman, Mark S; Comi, Giancarlo; Giovannoni, Gavin; Hartung, Hans-Peter; Arnold, Douglas; Kuhle, Jens; Block, Valerie; Munschauer, Frederick E; Sedel, Frédéric; Lublin, Fred D; Reingold, Stephen; Duquette, Pierre; Derfuss, Tobias; Fazekas, Franz... Journal: Lancet neurology Issue: Volume 19:Issue 12(2020) Page Start: 988 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The Relationship Between Brain MR Spectroscopy and Disability in Multiple Sclerosis: 20‐Year Data from the U.S. Glatiramer Acetate Extension Study. Issue 1 (23rd May 2016) Authors: Khan, Omar; Seraji‐Bozorgzad, Navid; Bao, Fen; Razmjou, Sara; Caon, Christina; Santiago, Carla; Latif, Zahid; Aronov, Rimma; Zak, Imad; Ashtamker, Natalia; Kolodny, Scott; Ford, Corey; Sidi, Yulia Journal: Journal of neuroimaging Issue: Volume 27:Issue 1(2017) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗